Tumour calcifications as a prognostic marker in glioblastoma patients treated with bevacizumab

Purpose: Glioblastoma (GBM) is the most common and lethal malignant primary brain tumor in adults and its prognosis remains very poor. Bevacizumab (BV) is an anti-angiogenic drug widely used in recurrent GBM. BV can induce GBM calcifications and some authors identified a possible correlation between...

Full description

Bibliographic Details
Main Author: Alexandra Maria Lopes Santos (author)
Format: masterThesis
Language:eng
Published: 2022
Subjects:
Medicina clínica
Clinical medicine
Online Access:https://hdl.handle.net/10216/142161
Country:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/142161

Internet

https://hdl.handle.net/10216/142161

Similar Items